Our results support the oncosuppressive role of HNF1B in prostate carcinoma, which may be silenced due to promoter methylation and other mechanisms, but not due to gene mutation, which seems to be very rare in PC. The gene discussed is HNF1B; the disease is prostate carcinoma.